A Joint Model Based on Deep Learning to Predict Multidrug-resistant Klebsiella Pneumoniae Liver Abscess
CLASS2401
Combining Image-clinical Model Based on Deep Learning and Radiomics to Predict Multidrug-resistant Klebsiella Pneumoniae Liver Abscess
1 other identifier
observational
550
1 country
1
Brief Summary
The goal of this observational study is to train a deep learning-based model to predict multidrug-resistant Klebsiella pneumoniae liver abscess and evaluate it on a multi-center database.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 3, 2024
CompletedFirst Posted
Study publicly available on registry
July 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedJuly 17, 2024
July 1, 2024
12 months
July 3, 2024
July 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Result of bacteria culture
The result of bacteria culture of abscess decides which group the patients belong. This result was obtained from bacteria culture tests which were done by department of laboratory medicine.
The first time before surgery or interventional process, usually within 1 week, up to 4 weeks.
Result of drug resistant test
Our destination is to find out the potential differences between Esbl(+) \& Esbl(-) liver abscess.
The first time before surgery or interventional process, usually within 1 week, up to 4 weeks.
Study Arms (2)
Patients with ESBL(-) liver abscess
Patients with ESBL(+) liver abscess
Eligibility Criteria
Pyogenic liver abscess patients in 14years of a multicenter project.
You may qualify if:
- Patients diagnosed as pyogenic liver abscess and was proved by surgery or interventional process.
- Patients had accepted abdominal enhance CT scans before surgery or interventional process.
You may not qualify if:
- Patients diagnosed with other types of liver abscess such as amoeba.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shengjing Hospitallead
- The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial)collaborator
- Guilin Medical University, Chinacollaborator
- Hebei General Hospitalcollaborator
- Xijing Hospitalcollaborator
- Hebei Medical University Third Hospitalcollaborator
- The First Affiliated Hospital of Dalian Medical Universitycollaborator
- The People's Hospital of Liaoning Provincecollaborator
- Fourth People's Hospital of Shenyangcollaborator
- Sir Run Run Shaw Hospitalcollaborator
Study Sites (1)
Shengjing hospital of China medical university
Shenyang, Liaoning, 110004, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
July 3, 2024
First Posted
July 17, 2024
Study Start
January 1, 2024
Primary Completion
December 30, 2024
Study Completion
March 1, 2025
Last Updated
July 17, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share